27776993|t|Lixisenatide attenuates the detrimental effects of amyloid beta protein on spatial working memory and hippocampal neurons in rats.
27776993|a|Type 2 diabetes mellitus(T2DM) is a risk factor of Alzheimer's disease (AD), which is most likely linked to impairments of insulin signaling in the brain. Hence, drugs enhancing insulin signaling may have therapeutic potential for AD. Lixisenatide, a novel long-lasting glucagon-like peptide 1 (GLP-1) analogue, facilitates insulin signaling and has neuroprotective properties. We previously reported the protective effects of lixisenatide on memory formation and synaptic plasticity. Here, we describe additional key neuroprotective properties of lixisenatide and its possible molecular and cellular mechanisms against AD-related impairments in rats. The results show that lixisenatide effectively alleviated amyloid beta protein (Abeta) 25-35-induced working memory impairment, reversed Abeta25-35-triggered cytotoxicity on hippocampal cell cultures, and prevented against Abeta25-35-induced suppression of the Akt-MEK1/2 signaling pathway. Lixisenatide also reduced the Abeta25-35 acute application induced intracellular calcium overload, which was abolished by U0126, a specific MEK1/2 inhibitor. These results further confirmed the neuroprotective and cytoprotective action of lixisenatide against Abeta-induced impairments, suggesting that the protective effects of lixisenatide may involve the activation of the Akt-MEK1/2 signaling pathway and the regulation of intracellular calcium homeostasis.
27776993	0	12	Lixisenatide	Chemical	MESH:C479460
27776993	125	129	rats	Species	10116
27776993	131	155	Type 2 diabetes mellitus	Disease	MESH:D003924
27776993	156	160	T2DM	Disease	
27776993	182	201	Alzheimer's disease	Disease	MESH:D000544
27776993	203	205	AD	Disease	MESH:D000544
27776993	362	364	AD	Disease	MESH:D000544
27776993	366	378	Lixisenatide	Chemical	MESH:C479460
27776993	401	424	glucagon-like peptide 1	Gene	24952
27776993	426	431	GLP-1	Gene	24952
27776993	558	570	lixisenatide	Chemical	MESH:C479460
27776993	679	691	lixisenatide	Chemical	MESH:C479460
27776993	751	753	AD	Disease	MESH:D000544
27776993	777	781	rats	Species	10116
27776993	805	817	lixisenatide	Chemical	MESH:C479460
27776993	892	909	memory impairment	Disease	MESH:D008569
27776993	941	953	cytotoxicity	Disease	MESH:D064420
27776993	1044	1047	Akt	Gene	24185
27776993	1048	1054	MEK1/2	Gene	170851;58960
27776993	1074	1086	Lixisenatide	Chemical	MESH:C479460
27776993	1155	1162	calcium	Chemical	MESH:D002118
27776993	1196	1201	U0126	Chemical	MESH:C113580
27776993	1214	1220	MEK1/2	Gene	170851;58960
27776993	1313	1325	lixisenatide	Chemical	MESH:C479460
27776993	1403	1415	lixisenatide	Chemical	MESH:C479460
27776993	1450	1453	Akt	Gene	24185
27776993	1454	1460	MEK1/2	Gene	170851;58960
27776993	1515	1522	calcium	Chemical	MESH:D002118
27776993	Negative_Correlation	MESH:C479460	MESH:D064420
27776993	Negative_Correlation	MESH:C479460	MESH:D008569
27776993	Association	MESH:C479460	58960
27776993	Negative_Correlation	MESH:C113580	MESH:C479460
27776993	Association	170851	24185
27776993	Negative_Correlation	MESH:C113580	170851
27776993	Association	MESH:C479460	MESH:D002118
27776993	Association	MESH:C479460	170851
27776993	Positive_Correlation	MESH:C479460	24185
27776993	Negative_Correlation	MESH:C113580	MESH:D002118
27776993	Negative_Correlation	MESH:C113580	58960
27776993	Association	24185	58960

